Safety and Efficacy of Allogeneic Hematopoetic Stem Cell Transplant (HSCT) after Treatment with Programmed Cell Death 1 (PD-1) Inhibitors

被引:0
作者
Merryman, Reid W. [1 ]
Kim, Haesook T. [2 ]
Zinzani, Pier Luigi [3 ]
Carlo-Stella, Carmelo [4 ]
Ansell, Stephen M. [5 ]
Halwani, Ahmad S. [6 ]
Perales, Miguel-Angel [7 ]
Ho, Vincent T. [8 ]
Antin, Joseph H. [8 ]
Ritz, Jerome [9 ]
Soiffer, Robert J. [8 ]
Armand, Philippe [10 ]
机构
[1] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA
[3] Univ Bologna, Inst Hematol L&A Seragnoli, Bologna, Italy
[4] Humanitas Clin & Res Ctr, Milan, Italy
[5] Mayo Clin, Rochester, MN USA
[6] Huntsman Canc Inst, Salt Lake City, UT USA
[7] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA
[8] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[9] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA
[10] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
[31]   Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction [J].
Wang, Yu ;
Huang, Kun ;
Gao, Yali ;
Yuan, Dandan ;
Ling, Lin ;
Liu, Jieqing ;
Wu, Sihai ;
Chen, Roufen ;
Li, He ;
Xiong, Yizu ;
Liu, Han ;
Ma, Junjie .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 229
[32]   Programmed Cell Death 1 (PD-1) Is Over Expressed in Giant Cell Tumor of the Bone and Adamantinoma [J].
Torabi, Alireza ;
Bryan, Brad A. ;
Amaya, Clarissa N. ;
Wians, Frank H. .
MODERN PATHOLOGY, 2017, 30 :26A-26A
[33]   Programmed Cell Death 1 (PD-1) Is Over Expressed in Giant Cell Tumor of the Bone and Adamantinoma [J].
Tombi, Alireza ;
Bryan, Brad A. ;
Amaya, Clarissa N. ;
Wians, Frank H. .
LABORATORY INVESTIGATION, 2017, 97 :26A-26A
[34]   Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate [J].
Santoro, Armando ;
Castagna, Luca ;
Magagnoli, Massimo ;
Bramanti, Stefania ;
Mariotti, Jacopo ;
Mazza, Rita ;
Morello, Lucia ;
Ricci, Francesca ;
Sarina, Barbara ;
De Philippis, Chiara ;
Sica, Simona ;
Rodari, Marcello ;
Sollini, Martina ;
Kirienko, Margarita ;
Giordano, Laura ;
Chiti, Arturo ;
Corradini, Paolo ;
Carlo-Stella, Carmelo .
BLOOD, 2018, 132
[35]   Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics [J].
Cassol, Clarissa A. ;
Owen, Dwight ;
Kendra, Kari ;
Braga, Juarez R. ;
Frankel, Wendy L. ;
Arnold, Christina A. .
HISTOPATHOLOGY, 2020, 77 (02) :240-249
[36]   Clinical impact of programmed cell death ligand 1 (PD-L1), programmed cell death 1 (PD-1), and CD8 expression in pancreatic cancer [J].
Shim, Hyun-Jeong ;
Hwang, Jun-Eul ;
Jung, Sook-In ;
Lee, Kyung-Hwa ;
Chung, Ik-Joo ;
Cho, Sang-Hee .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[37]   Immunotherapy efficacy of programmed cell death 1 (PD-1) versus programmed death ligand-1 (PD-L1) inhibitors in non-small cell lung cancer (NSCLC) patients: A systematic review and meta-analysis. [J].
Yang, Danrong ;
Cui, Longgang ;
Zhang, Yuzi ;
Zhao, Zhengyi ;
Bai, Yuezong .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[38]   Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer [J].
Neelima Vidula ;
Christina Yau ;
Hope S. Rugo .
Breast Cancer Research and Treatment, 2021, 187 :387-395
[39]   Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer [J].
Vidula, Neelima ;
Yau, Christina ;
Rugo, Hope S. .
BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) :387-395
[40]   Association of polymorphisms in the programmed cell death 1 (PD-1) and PD-1 ligand genes with ankylosing spondylitis in a Chinese population [J].
Yang, Q. ;
Liu, Y. ;
Liu, D. ;
Zhang, Y. ;
Mu, K. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) :13-18